Ames Seed Capital

VetMeasure, Inc. is a company specializing in the design and manufacture of health monitoring devices for animals. Founded in 2015 and based in Ames, Iowa, VetMeasure offers a product known as MeasureOn, a wearable harness that enables veterinarians to remotely monitor vital health statistics of dogs and other pets. This device tracks heart and pulse rates, respiration, body temperature, and ambient conditions such as temperature and humidity. By leveraging Bluetooth technology, MeasureOn provides real-time data, allowing both veterinarians and pet owners to assess an animal's health status, particularly following surgical procedures or during recovery from illness. The company's innovative approach aims to enhance the care and monitoring of pets, ensuring timely and accurate health assessments.

Founded in 2014, Pitchly is a SaaS company based in Des Moines, Iowa. It provides a cloud-based platform that enables non-technical users to create data-infused real-time PowerPoint and Word documents linked to internal business data sources. The platform aggregates disparate information, reducing time spent by 93% and eliminating errors, while also allowing custom forms for data population.

Automed Inc., established in 2012 and headquartered in Belconnen, Australia, specializes in designing and manufacturing automatic livestock medication systems. The company's flagship product, automed, is a pioneering system that automatically calculates, delivers, and records livestock treatments, helping producers manage operations efficiently. It offers adapters for various medication administration methods, including injection, drench, pour-on, and intra-nasal. The automed system seamlessly integrates with existing farm management tools, reducing costs, improving efficiency, and enhancing compliance through real-time data recording.

FindBoB is a tool designed for financial advisors and insurance agents to plan for growth, transition, and succession. It employs machine learning and gamification elements to protect assets.

NewLink Genetics is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative immuno-oncology products aimed at enhancing the lives of cancer patients. Established over 15 years ago, the company is driven by a team of experienced industry professionals and physician-scientists. Inspired by personal cancer experiences, NewLink Genetics is committed to advancing research and development in cancer treatments. The company's mission focuses on transforming the cancer treatment landscape and making a meaningful impact on patient outcomes.

NewLink Genetics is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative immuno-oncology products aimed at enhancing the lives of cancer patients. Established over 15 years ago, the company is driven by a team of experienced industry professionals and physician-scientists. Inspired by personal cancer experiences, NewLink Genetics is committed to advancing research and development in cancer treatments. The company's mission focuses on transforming the cancer treatment landscape and making a meaningful impact on patient outcomes.